Navigation Links
Zix Corporation CEO Provides Corporate Update for Second Quarter 2009
Date:7/7/2009

announcement that ZixCorp is reviewing strategic alternatives for its e-Prescribing service, we continue with business as usual with respect to executing our existing contracts and providing services to our customers. Our PocketScript business achieved our e-Prescribing deployment guidance for the second quarter with approximately 325 deployments. ZixCorp processed over 2.5 million scripts in the quarter, an increase of approximately 19 percent compared with the same quarter in 2008. In light of our announcement concerning the assessment of this business, we are no longer in negotiations for a large contract with a national payor that could have almost doubled the number of currently active prescribers. We are, however, engaged in payor discussions to improve the profitability of our e-Prescribing business through new pricing arrangements and service enhancements."

ZixCorp to Announce Second Quarter 2009 Results on July 28

The Company's second quarter 2009 operating results will be released after close of the U.S. financial markets on July 28, 2009. A conference call will be held to discuss this information on July 28 at 5:00 p.m. ET.

A live Webcast of the conference call will be available on the investor relations portion of ZixCorp's Web site at http://investor.zixcorp.com. Alternatively, participants can listen to the conference call by dialing 617-213-8064 or toll-free 866-770-7051 and entering access code 40200276. An audio replay of the conference will be available until August 4, by dialing 617-801-6888 or toll-free 888-286-8010, and entering the access code 36658027, and after that date via Webcast from the Company's Web site.

About Zix Corporation

Zix Corporation is the leader in email encryption and payor sponsored e-prescribing services. ZixCorp offers the simplicity of Software as a Service with the convenie
'/>"/>

SOURCE Zix Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...areandCalgaryScientificInc.,aleadingproviderofsoft...ofAegis(TM)Breast4DAdvancedVisualizationsoftware. ...ootprintWebclientbasedmedicalimagingofferinginthem...forzero-footprintaccess-requiringnosoftwaredownloa...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...vaccine carried into the body on a carefully engin...ccessfully eliminate tumors in mammals, scientists...ional Medicine . , The new approach, pioneered b...sity, uses plastic disks impregnated with tumor-sp...program the mammalian immune system to attack tumo...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
.... scientists discover an effective method of vacci...ium Yersinia pestis//, with the details of their s...ture Immunology. Egil Lien and his colleagues a...fatty sugars in the development of an effective va...
... Waters’ missionary work to spread the Gospel to f...ecades, but it left his head pounding.// Begi...t eventually forced him to return home. Medi... caused facial throbbing, until he came to the Eug...
... blame yourself, if your taste buds get tickled at...re mention! A recent investigation into the reaso...arian food has shown that such tendencies are gene...be in the pink of health. To understand such incli...
...rotein helps lower total cholesterol, low-density ...ghtly raises high-density lipid “good” cholesterol...ed in the Sept. 1, 2006 issue of The American Jour...or the prevention and treatment of high blood chol...
...ent study reveals that short sessions (a few minut... same results as moderate exercises done for hours...inesiology at McMaster University and his team con...g finding from our study was the remarkably simila...
...to - Those Canadians who live in far-flung areas r...to the city-dwellers, primarily due to an increase...idental injury, as stated by a report released by ...nt in the god-forsaken areas of rural Canada, in s...
Other Medicine News:Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 2Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 3Health News:Rural Canadians, Take Care Of Your Health 2
(Date:11/25/2009).../PRNewswire-FirstCall/--HeskaCorporation(HSKA);("H...ecialtyproductstotheveterinaryindustry,announcedto...supplyofbloodgasproductsandaffiliatedconsumablesfo...com.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "H...ieldofadvancedpoint-of-carediagnostics,"commentedM...
(Date:11/25/2009)...wswire/--BioTrendsResearchGroup,Inc.releasedWave1o...tinamulti-phasesyndicatedmarketresearchprojecttrac...productlaunchthroughthefirstsixmonthsofavailabilit...onfrom75uniqueDermatologistsandqualitativeinformat...elara,obstaclestouse,typicalpatienttypes,productpe...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Herley Reports Fourth Quarter and Year End Results 59611 1Herley Reports Fourth Quarter and Year End Results 59611 2Herley Reports Fourth Quarter and Year End Results 59611 3Herley Reports Fourth Quarter and Year End Results 59611 4Herley Reports Fourth Quarter and Year End Results 59611 5Herley Reports Fourth Quarter and Year End Results 59611 6Herley Reports Fourth Quarter and Year End Results 59611 7Herley Reports Fourth Quarter and Year End Results 59611 8Herley Reports Fourth Quarter and Year End Results 59611 9Herley Reports Fourth Quarter and Year End Results 59611 10Herley Reports Fourth Quarter and Year End Results 59611 11Herley Reports Fourth Quarter and Year End Results 59611 12Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Scientists use math modeling to predict unknown biological mechanism of regulation 14500 1Scientists use math modeling to predict unknown biological mechanism of regulation 14500 2
...ermanent version of the glasses ...vative prism glasses can,significantly improve the...nopia, a condition that blinds half the visual fie...ch were invented by Dr. Eli Peli, a Senior,Scienti...ted in the first,community-based multi- center tri...
...utics, Inc.,announced the successful completion of...nd, VEL-0230, which the company is investigating a...her bone diseases. In,extensive preclinical studie...ory agent that also stimulates bone formation and ...ristics strongly suggest this drug,may be an impor...
Other Medicine Technology:Prism Glasses Expand the View for Patients with Hemianopia 2Prism Glasses Expand the View for Patients with Hemianopia 3Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2
LD Lactate –> Pyruvate
Rheumatoid Factor Latex Test (RF)
IgG (sample dilution, 1-shot only) (Liquid)
CRP (Complete Kit with Disposible Cards)
Medicine Products: